Advertisement

Topics

Test identifies breast cancer patients with lowest risk of death

07:00 EDT 29 Jun 2017 | Medical Xpress

A molecular test can pinpoint which patients will have a very low risk of death from breast cancer even 20 years after diagnosis and tumor removal, according to a new clinical study led by UC San Francisco in collaboration with colleagues in Sweden. As a result, "ultralow" risk patients could be treated less aggressively and overtreatment avoided, leading to fewer toxic effects.

Original Article: Test identifies breast cancer patients with lowest risk of death

NEXT ARTICLE

More From BioPortfolio on "Test identifies breast cancer patients with lowest risk of death"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...